Alerts will be sent to your verified email
Verify Email
UNICK
|
Unick Fix-A-Form
|
Vilin Bio Med
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.15 % | 3.34 % | 11.51 % |
|
5yr average Equity Multiplier
|
2.49 | 1.75 | 3.24 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 0.81 | 0.88 |
|
5yr Avg Net Profit Margin
|
4.16 % | 2.69 % | 1.44 % |
|
Price to Book
|
1.11 | 0.0 | 0.48 |
|
P/E
|
13.63 | 228.49 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
21.15 Days | 147.94 Days | 57.8 Days |
|
Inventory Days
|
48.34 Days | 58.04 Days | 76.41 Days |
|
Days Receivable
|
79.56 Days | 130.3 Days | 195.39 Days |
|
Days Payable
|
119.31 Days | 44.85 Days | 179.71 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | 1.79 | 2.65 |
|
5yr Avg ROCE
|
12.8 % | 9.64 % | 22.81 % |
|
5yr Avg Operating Profit Margin
|
14.14 % | 9.07 % | 10.92 % |
|
5 yr average Debt to Equity
|
0.86 | 0.57 | 0.87 |
|
5yr CAGR Net Profit
|
-7.47 % | 0.0 | n/a |
|
5yr Average Return on Assets
|
3.64 % | 1.96 % | 3.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.57 % | 63.89 % | 70.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.88 % |
|
Change in Promoter Holding (3 Yrs)
|
35.92 % | -0.63 % | -0.54 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Unick Fix-A-Form
|
Vilin Bio Med
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|